{
    "title": "Sanofi hones in on type 1 diabetes in $2.9 bln Provention Bio deal",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11852929/Frances-Sanofi-acquire-US-based-Provention-Bio-2-9-bln.html",
    "date": "2023-03-13",
    "keywords": [
        "drug",
        "type",
        "development",
        "provention",
        "sanofi",
        "company",
        "burger",
        "dina",
        "work",
        "pipeline",
        "tzield",
        "acquisition",
        "trade",
        "stage",
        "march",
        "sa",
        "bio",
        "inc",
        "therapy",
        "deal",
        "copromotion",
        "agreement",
        "drugmaker",
        "ownership",
        "quarter",
        "growth",
        "asthma",
        "dupixent",
        "premarket",
        "close",
        "share",
        "cash",
        "speed",
        "premium",
        "process",
        "bid",
        "pharma",
        "analyst",
        "david",
        "hoang",
        "afternoon",
        "paris",
        "maker",
        "insulin",
        "toujeo",
        "lantus",
        "quit",
        "executive",
        "officer",
        "paul",
        "hudson",
        "month",
        "promise",
        "commitment",
        "obesity",
        "biotech",
        "firm",
        "approval",
        "year",
        "onset",
        "reporting",
        "kartit",
        "mariam",
        "e",
        "sunny",
        "bengaluru",
        "editing",
        "kim",
        "coghill",
        "donovan",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}